jueves, 10 de noviembre de 2016

Ninth Annual Sentinel Initiative Public Workshop- Drug Information Update

FDA Logo, hands holding pills
The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

The Food and Drug Administration (FDA) is announcing a public workshop to be held on February 2, 2017, entitled “Ninth Annual Sentinel Initiative Public Workshop.” Convened by the Duke-Margolis Center for Health Policy at Duke University and supported by a cooperative agreement with the FDA, this 1-day workshop will bring the stakeholder community together to discuss a variety of topics on active medical product surveillance. Topics will include an update on the state of the FDA's Sentinel Initiative, an overview of the current state of Sentinel System safety surveillance activities, and accomplishments of the Sentinel System in 2016. In addition, panelists will discuss the future of the Sentinel System and opportunities to expand its medical product surveillance capabilities. This workshop will also engage stakeholders to discuss current and emerging Sentinel Initiative projects.
Date:February 2, 2017
Time:9:00 a.m. to 4:30 p.m.
Location:Kaiser Family Foundation
Barbara Jordan Conference Center
1330 G St NW, Washington, DC 20005

For additional information, please visit: